Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Testosterone | 86 | 2024 | 2471 | 5.760 |
Why?
|
Androgens | 31 | 2023 | 1291 | 2.660 |
Why?
|
Delirium | 35 | 2024 | 1663 | 2.650 |
Why?
|
Hypogonadism | 16 | 2024 | 800 | 2.450 |
Why?
|
Mobility Limitation | 25 | 2023 | 400 | 2.360 |
Why?
|
Sex Hormone-Binding Globulin | 20 | 2024 | 546 | 2.230 |
Why?
|
Muscle Strength | 18 | 2023 | 618 | 1.800 |
Why?
|
Sarcopenia | 11 | 2021 | 372 | 1.700 |
Why?
|
Accidental Falls | 16 | 2021 | 1056 | 1.610 |
Why?
|
Erectile Dysfunction | 12 | 2024 | 451 | 1.600 |
Why?
|
Body Composition | 25 | 2024 | 2416 | 1.570 |
Why?
|
Hand Strength | 12 | 2020 | 452 | 1.560 |
Why?
|
Aging | 34 | 2023 | 8650 | 1.450 |
Why?
|
Estradiol | 16 | 2024 | 1933 | 1.450 |
Why?
|
Hormone Replacement Therapy | 15 | 2024 | 754 | 1.420 |
Why?
|
Estrone | 9 | 2018 | 232 | 1.410 |
Why?
|
Geriatric Assessment | 16 | 2023 | 1404 | 1.070 |
Why?
|
Androgen Antagonists | 7 | 2024 | 1442 | 1.030 |
Why?
|
Walking | 9 | 2021 | 1188 | 1.020 |
Why?
|
Gait | 13 | 2023 | 812 | 0.980 |
Why?
|
Aged | 180 | 2024 | 168218 | 0.900 |
Why?
|
Muscle, Skeletal | 15 | 2024 | 4902 | 0.880 |
Why?
|
Postural Balance | 10 | 2020 | 617 | 0.880 |
Why?
|
Independent Living | 18 | 2023 | 567 | 0.870 |
Why?
|
Frail Elderly | 5 | 2023 | 751 | 0.750 |
Why?
|
Recovery of Function | 6 | 2020 | 2970 | 0.720 |
Why?
|
Gait Disorders, Neurologic | 2 | 2021 | 238 | 0.700 |
Why?
|
Muscle Weakness | 6 | 2020 | 413 | 0.690 |
Why?
|
Bone Density | 14 | 2018 | 3533 | 0.680 |
Why?
|
Phosphodiesterase 5 Inhibitors | 4 | 2013 | 101 | 0.660 |
Why?
|
Male | 197 | 2024 | 358747 | 0.660 |
Why?
|
Prediabetic State | 1 | 2024 | 547 | 0.610 |
Why?
|
Femur | 3 | 2008 | 1302 | 0.580 |
Why?
|
Diagnostic Techniques, Endocrine | 1 | 2017 | 43 | 0.570 |
Why?
|
Gonadal Steroid Hormones | 5 | 2023 | 701 | 0.560 |
Why?
|
Dementia | 7 | 2022 | 2650 | 0.550 |
Why?
|
Insulin Resistance | 8 | 2024 | 3941 | 0.550 |
Why?
|
Patient Readmission | 6 | 2021 | 3261 | 0.520 |
Why?
|
Aged, 80 and over | 64 | 2024 | 58683 | 0.520 |
Why?
|
Humans | 237 | 2024 | 758406 | 0.520 |
Why?
|
Postoperative Complications | 22 | 2024 | 15637 | 0.500 |
Why?
|
Luteinizing Hormone | 8 | 2024 | 820 | 0.500 |
Why?
|
Prospective Studies | 55 | 2024 | 54137 | 0.490 |
Why?
|
Hip Fractures | 4 | 2020 | 987 | 0.480 |
Why?
|
Prostatic Neoplasms | 8 | 2024 | 11336 | 0.470 |
Why?
|
Exercise | 8 | 2020 | 5788 | 0.470 |
Why?
|
Double-Blind Method | 32 | 2024 | 12262 | 0.460 |
Why?
|
Longitudinal Studies | 23 | 2023 | 14490 | 0.450 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 4 | 2018 | 691 | 0.450 |
Why?
|
Genes, Y-Linked | 1 | 2013 | 12 | 0.450 |
Why?
|
Pacemaker, Artificial | 2 | 2017 | 808 | 0.440 |
Why?
|
Cross-Sectional Studies | 39 | 2023 | 25956 | 0.440 |
Why?
|
Cerebrovascular Circulation | 4 | 2017 | 2731 | 0.430 |
Why?
|
Middle Aged | 99 | 2024 | 219568 | 0.430 |
Why?
|
Malnutrition | 1 | 2020 | 639 | 0.430 |
Why?
|
Kyphosis | 4 | 2019 | 237 | 0.410 |
Why?
|
Activities of Daily Living | 8 | 2023 | 2414 | 0.400 |
Why?
|
Analgesics, Opioid | 8 | 2022 | 3765 | 0.400 |
Why?
|
Absorptiometry, Photon | 13 | 2021 | 1735 | 0.390 |
Why?
|
Andropause | 2 | 2008 | 8 | 0.390 |
Why?
|
Motor Activity | 2 | 2012 | 2685 | 0.380 |
Why?
|
Dietary Proteins | 5 | 2021 | 949 | 0.380 |
Why?
|
Models, Statistical | 3 | 2020 | 5070 | 0.380 |
Why?
|
Dihydrotestosterone | 4 | 2024 | 195 | 0.370 |
Why?
|
Research Design | 6 | 2020 | 6157 | 0.370 |
Why?
|
Ataxia | 3 | 2017 | 305 | 0.360 |
Why?
|
Dietary Supplements | 7 | 2020 | 3387 | 0.360 |
Why?
|
Retinoscopy | 1 | 2010 | 26 | 0.350 |
Why?
|
Cardiovascular Diseases | 18 | 2024 | 15399 | 0.350 |
Why?
|
Chromatography, Liquid | 6 | 2013 | 986 | 0.350 |
Why?
|
Arrhythmias, Cardiac | 2 | 2017 | 2248 | 0.330 |
Why?
|
Female | 108 | 2024 | 390323 | 0.330 |
Why?
|
Body Mass Index | 18 | 2020 | 12876 | 0.320 |
Why?
|
Thoracic Vertebrae | 3 | 2019 | 596 | 0.320 |
Why?
|
Refraction, Ocular | 1 | 2010 | 179 | 0.320 |
Why?
|
Consensus | 5 | 2020 | 3099 | 0.310 |
Why?
|
Weight Loss | 3 | 2016 | 2671 | 0.310 |
Why?
|
Refractive Errors | 1 | 2010 | 145 | 0.310 |
Why?
|
Boston | 18 | 2023 | 9304 | 0.290 |
Why?
|
Alzheimer Disease | 7 | 2024 | 8544 | 0.290 |
Why?
|
Tandem Mass Spectrometry | 6 | 2013 | 1186 | 0.290 |
Why?
|
Gastric Bypass | 1 | 2016 | 817 | 0.290 |
Why?
|
Defibrillators, Implantable | 1 | 2017 | 1487 | 0.290 |
Why?
|
Cognition | 12 | 2023 | 6953 | 0.280 |
Why?
|
Intra-Abdominal Fat | 2 | 2023 | 608 | 0.280 |
Why?
|
Cohort Studies | 26 | 2023 | 41256 | 0.280 |
Why?
|
Antihypertensive Agents | 2 | 2023 | 2016 | 0.280 |
Why?
|
Hysterectomy | 3 | 2019 | 904 | 0.270 |
Why?
|
Adult | 70 | 2023 | 219935 | 0.270 |
Why?
|
Sulfones | 3 | 2013 | 446 | 0.270 |
Why?
|
Femur Neck | 5 | 2018 | 312 | 0.260 |
Why?
|
Massachusetts | 11 | 2022 | 8823 | 0.260 |
Why?
|
Libido | 1 | 2006 | 119 | 0.260 |
Why?
|
Cognition Disorders | 5 | 2018 | 3975 | 0.260 |
Why?
|
Risk Factors | 38 | 2024 | 73809 | 0.250 |
Why?
|
Fontan Procedure | 4 | 2012 | 791 | 0.250 |
Why?
|
Health Status | 8 | 2018 | 4071 | 0.250 |
Why?
|
Obesity, Morbid | 1 | 2016 | 1277 | 0.240 |
Why?
|
Tai Ji | 2 | 2019 | 287 | 0.240 |
Why?
|
Quality of Life | 13 | 2023 | 13285 | 0.230 |
Why?
|
Remission, Spontaneous | 3 | 2011 | 384 | 0.230 |
Why?
|
Geriatric Nursing | 2 | 2021 | 39 | 0.230 |
Why?
|
Leg Injuries | 4 | 2007 | 178 | 0.220 |
Why?
|
Physicians | 1 | 2022 | 4580 | 0.220 |
Why?
|
Disability Evaluation | 4 | 2020 | 1825 | 0.220 |
Why?
|
Atrophy | 3 | 2024 | 1627 | 0.220 |
Why?
|
Age Factors | 15 | 2020 | 18358 | 0.220 |
Why?
|
Prevalence | 12 | 2020 | 15651 | 0.220 |
Why?
|
Erythropoietin | 3 | 2018 | 719 | 0.210 |
Why?
|
Incidence | 14 | 2024 | 21272 | 0.210 |
Why?
|
5-alpha Reductase Inhibitors | 2 | 2016 | 117 | 0.210 |
Why?
|
Urinary Retention | 1 | 2023 | 106 | 0.210 |
Why?
|
Fluoroimmunoassay | 2 | 2013 | 30 | 0.210 |
Why?
|
Severity of Illness Index | 12 | 2023 | 15785 | 0.210 |
Why?
|
Hospitalization | 11 | 2022 | 10652 | 0.200 |
Why?
|
Erythropoiesis | 2 | 2018 | 682 | 0.200 |
Why?
|
Fractures, Bone | 4 | 2022 | 2040 | 0.200 |
Why?
|
Exercise Test | 5 | 2020 | 2121 | 0.200 |
Why?
|
Psychometrics | 4 | 2022 | 3052 | 0.200 |
Why?
|
Adipose Tissue | 3 | 2023 | 3299 | 0.200 |
Why?
|
Oxygen Consumption | 3 | 2018 | 1845 | 0.200 |
Why?
|
Follow-Up Studies | 18 | 2019 | 39059 | 0.200 |
Why?
|
Administration, Cutaneous | 7 | 2020 | 712 | 0.200 |
Why?
|
Liver | 4 | 2024 | 7502 | 0.200 |
Why?
|
Ergocalciferols | 2 | 2013 | 110 | 0.190 |
Why?
|
Health Education | 2 | 2019 | 1049 | 0.190 |
Why?
|
Logistic Models | 12 | 2020 | 13276 | 0.190 |
Why?
|
Life Style | 5 | 2012 | 3886 | 0.190 |
Why?
|
Socioeconomic Factors | 7 | 2020 | 7818 | 0.190 |
Why?
|
Depression | 8 | 2024 | 8057 | 0.190 |
Why?
|
Polycythemia | 2 | 2013 | 125 | 0.190 |
Why?
|
Reference Values | 7 | 2017 | 4919 | 0.190 |
Why?
|
Loneliness | 1 | 2023 | 196 | 0.190 |
Why?
|
Physical Fitness | 3 | 2020 | 732 | 0.180 |
Why?
|
Estrogens | 3 | 2012 | 1520 | 0.180 |
Why?
|
Lower Extremity | 3 | 2019 | 1188 | 0.180 |
Why?
|
Cerebral Cortex | 3 | 2024 | 5759 | 0.180 |
Why?
|
Vitamin D | 6 | 2018 | 3283 | 0.180 |
Why?
|
Affect | 3 | 2018 | 1480 | 0.180 |
Why?
|
Multivariate Analysis | 11 | 2017 | 12096 | 0.170 |
Why?
|
Baltimore | 1 | 2020 | 230 | 0.170 |
Why?
|
Confidence Intervals | 6 | 2011 | 2925 | 0.170 |
Why?
|
Aspirin | 2 | 2022 | 3131 | 0.170 |
Why?
|
Gels | 5 | 2023 | 419 | 0.170 |
Why?
|
Health Surveys | 7 | 2020 | 4064 | 0.170 |
Why?
|
Polymorphism, Genetic | 1 | 2010 | 4284 | 0.170 |
Why?
|
3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 2 | 2017 | 70 | 0.170 |
Why?
|
Antimicrobial Cationic Peptides | 2 | 2013 | 354 | 0.170 |
Why?
|
Dose-Response Relationship, Drug | 10 | 2019 | 10748 | 0.170 |
Why?
|
Risk Assessment | 14 | 2021 | 23884 | 0.160 |
Why?
|
Treatment Outcome | 24 | 2024 | 64378 | 0.160 |
Why?
|
Nurse's Role | 1 | 2020 | 188 | 0.160 |
Why?
|
Hydrocortisone | 1 | 2007 | 1802 | 0.160 |
Why?
|
Bone Remodeling | 2 | 2017 | 579 | 0.160 |
Why?
|
Health Services for the Aged | 1 | 2021 | 259 | 0.160 |
Why?
|
Leuprolide | 2 | 2018 | 314 | 0.160 |
Why?
|
Placebos | 5 | 2018 | 1661 | 0.160 |
Why?
|
Medication Reconciliation | 1 | 2020 | 153 | 0.160 |
Why?
|
Osteoporosis | 3 | 2018 | 1598 | 0.160 |
Why?
|
Leg | 1 | 2023 | 1087 | 0.160 |
Why?
|
Piperazines | 3 | 2013 | 2511 | 0.150 |
Why?
|
Nursing Homes | 3 | 2022 | 1080 | 0.150 |
Why?
|
Lumbar Vertebrae | 4 | 2019 | 1868 | 0.150 |
Why?
|
Radius | 3 | 2011 | 440 | 0.150 |
Why?
|
Eunuchism | 1 | 2017 | 19 | 0.150 |
Why?
|
Receptors, Androgen | 3 | 2016 | 1077 | 0.150 |
Why?
|
Aromatase | 1 | 2018 | 147 | 0.150 |
Why?
|
Europe | 2 | 2017 | 3420 | 0.150 |
Why?
|
Disease Progression | 8 | 2018 | 13468 | 0.150 |
Why?
|
Agrin | 1 | 2017 | 75 | 0.150 |
Why?
|
Neuropsychological Tests | 7 | 2020 | 7021 | 0.140 |
Why?
|
Confusion | 2 | 2016 | 279 | 0.140 |
Why?
|
Patient Care Management | 1 | 2020 | 302 | 0.140 |
Why?
|
Ankle | 1 | 2020 | 349 | 0.140 |
Why?
|
Pharmacoepidemiology | 1 | 2020 | 350 | 0.140 |
Why?
|
Predictive Value of Tests | 9 | 2020 | 15225 | 0.140 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2018 | 296 | 0.140 |
Why?
|
Wounds and Injuries | 3 | 2018 | 2476 | 0.130 |
Why?
|
Reference Standards | 2 | 2017 | 1003 | 0.130 |
Why?
|
Gonadotrophs | 1 | 2016 | 19 | 0.130 |
Why?
|
Antineoplastic Agents, Hormonal | 3 | 2023 | 1530 | 0.130 |
Why?
|
Long-Term Care | 1 | 2020 | 631 | 0.130 |
Why?
|
Spinal Curvatures | 1 | 2016 | 67 | 0.130 |
Why?
|
Public Housing | 1 | 2017 | 140 | 0.130 |
Why?
|
Cause of Death | 2 | 2024 | 3675 | 0.130 |
Why?
|
Pain Perception | 1 | 2017 | 196 | 0.130 |
Why?
|
Mental Health | 3 | 2023 | 3234 | 0.130 |
Why?
|
Finasteride | 1 | 2016 | 90 | 0.130 |
Why?
|
Endocrine System Diseases | 2 | 2008 | 249 | 0.130 |
Why?
|
Reproducibility of Results | 8 | 2022 | 20055 | 0.130 |
Why?
|
Resistance Training | 1 | 2017 | 185 | 0.130 |
Why?
|
Time Factors | 13 | 2024 | 39872 | 0.130 |
Why?
|
Prostatectomy | 1 | 2024 | 1956 | 0.120 |
Why?
|
Mortality | 3 | 2020 | 2886 | 0.120 |
Why?
|
Motor Skills | 1 | 2018 | 519 | 0.120 |
Why?
|
Accidents, Home | 1 | 2015 | 71 | 0.120 |
Why?
|
Blood Chemical Analysis | 1 | 2017 | 437 | 0.120 |
Why?
|
Craniocerebral Trauma | 1 | 2019 | 491 | 0.120 |
Why?
|
Magnetic Resonance Imaging | 13 | 2024 | 36284 | 0.120 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 748 | 0.120 |
Why?
|
Videoconferencing | 1 | 2017 | 203 | 0.120 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 2016 | 189 | 0.120 |
Why?
|
Heart Defects, Congenital | 4 | 2012 | 4673 | 0.120 |
Why?
|
Sensory Aids | 1 | 2014 | 40 | 0.120 |
Why?
|
Institutionalization | 1 | 2015 | 105 | 0.120 |
Why?
|
United States | 18 | 2022 | 72136 | 0.120 |
Why?
|
Inheritance Patterns | 1 | 2016 | 340 | 0.120 |
Why?
|
Cardiovascular System | 1 | 2021 | 835 | 0.120 |
Why?
|
Orthopedic Procedures | 3 | 2020 | 1263 | 0.120 |
Why?
|
Shoes | 1 | 2014 | 94 | 0.110 |
Why?
|
Anemia | 1 | 2023 | 1504 | 0.110 |
Why?
|
Vascular Resistance | 1 | 2017 | 930 | 0.110 |
Why?
|
Patients | 1 | 2020 | 904 | 0.110 |
Why?
|
Motor Cortex | 1 | 2021 | 997 | 0.110 |
Why?
|
Football | 1 | 2019 | 502 | 0.110 |
Why?
|
Diet Records | 1 | 2015 | 427 | 0.110 |
Why?
|
Catastrophization | 1 | 2017 | 347 | 0.110 |
Why?
|
Health Services Research | 1 | 2021 | 1812 | 0.110 |
Why?
|
Spleen | 2 | 2017 | 2296 | 0.110 |
Why?
|
Analgesics | 1 | 2020 | 1064 | 0.110 |
Why?
|
Nutrition Assessment | 1 | 2017 | 726 | 0.110 |
Why?
|
Comorbidity | 6 | 2019 | 10495 | 0.110 |
Why?
|
Glucose | 2 | 2024 | 4336 | 0.110 |
Why?
|
Health Care Costs | 3 | 2022 | 3245 | 0.110 |
Why?
|
Follicle Stimulating Hormone | 2 | 2016 | 725 | 0.110 |
Why?
|
Prostate | 3 | 2023 | 1791 | 0.110 |
Why?
|
Interview, Psychological | 1 | 2016 | 809 | 0.110 |
Why?
|
Limb Salvage | 2 | 2008 | 464 | 0.110 |
Why?
|
Self Report | 2 | 2022 | 3714 | 0.110 |
Why?
|
Aorta, Abdominal | 1 | 2016 | 625 | 0.110 |
Why?
|
Sexual Dysfunction, Physiological | 3 | 2016 | 357 | 0.110 |
Why?
|
Telephone | 1 | 2016 | 625 | 0.110 |
Why?
|
Cytokines | 2 | 2018 | 7338 | 0.110 |
Why?
|
Monitoring, Ambulatory | 1 | 2016 | 352 | 0.100 |
Why?
|
Vibration | 1 | 2014 | 327 | 0.100 |
Why?
|
Noise | 1 | 2014 | 280 | 0.100 |
Why?
|
Body Height | 2 | 2010 | 1567 | 0.100 |
Why?
|
Sexuality | 1 | 2014 | 179 | 0.100 |
Why?
|
25-Hydroxyvitamin D 2 | 1 | 2012 | 40 | 0.100 |
Why?
|
Models, Biological | 2 | 2011 | 9460 | 0.100 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2021 | 10146 | 0.100 |
Why?
|
Young Adult | 13 | 2023 | 58808 | 0.100 |
Why?
|
Models, Chemical | 1 | 2014 | 610 | 0.100 |
Why?
|
Body Weight | 5 | 2013 | 4603 | 0.100 |
Why?
|
Heart Bypass, Right | 1 | 2012 | 75 | 0.100 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2015 | 431 | 0.100 |
Why?
|
Azasteroids | 1 | 2012 | 37 | 0.100 |
Why?
|
Length of Stay | 5 | 2020 | 6439 | 0.100 |
Why?
|
Alopecia | 1 | 2016 | 414 | 0.100 |
Why?
|
Diuretics | 1 | 2015 | 610 | 0.100 |
Why?
|
Blood Glucose | 4 | 2021 | 6346 | 0.100 |
Why?
|
Diabetes Mellitus | 3 | 2023 | 5816 | 0.100 |
Why?
|
Postoperative Care | 2 | 2016 | 1471 | 0.100 |
Why?
|
Adiposity | 2 | 2012 | 1858 | 0.100 |
Why?
|
Calcium Channel Blockers | 1 | 2015 | 694 | 0.100 |
Why?
|
Regional Blood Flow | 1 | 2015 | 1486 | 0.100 |
Why?
|
Interleukin-6 | 2 | 2020 | 3208 | 0.100 |
Why?
|
Caregivers | 2 | 2021 | 2225 | 0.100 |
Why?
|
Calcitriol | 1 | 2013 | 297 | 0.100 |
Why?
|
Calcifediol | 1 | 2012 | 161 | 0.090 |
Why?
|
Bone Density Conservation Agents | 1 | 2018 | 794 | 0.090 |
Why?
|
Anabolic Agents | 1 | 2013 | 252 | 0.090 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2021 | 2269 | 0.090 |
Why?
|
Diet Surveys | 1 | 2015 | 1161 | 0.090 |
Why?
|
Chemistry, Clinical | 1 | 2011 | 64 | 0.090 |
Why?
|
Radius Fractures | 1 | 2017 | 513 | 0.090 |
Why?
|
Dyslipidemias | 1 | 2018 | 867 | 0.090 |
Why?
|
Atherosclerosis | 2 | 2018 | 3401 | 0.090 |
Why?
|
Ankle Brachial Index | 1 | 2011 | 159 | 0.090 |
Why?
|
Physical Therapy Modalities | 1 | 2014 | 536 | 0.090 |
Why?
|
Vitamin D Deficiency | 2 | 2012 | 1377 | 0.090 |
Why?
|
Optometry | 1 | 2010 | 29 | 0.090 |
Why?
|
Testis | 1 | 2013 | 794 | 0.090 |
Why?
|
Executive Function | 2 | 2018 | 1374 | 0.090 |
Why?
|
Continuity of Patient Care | 1 | 2017 | 1067 | 0.090 |
Why?
|
Accommodation, Ocular | 1 | 2010 | 47 | 0.090 |
Why?
|
Impotence, Vasculogenic | 1 | 2009 | 12 | 0.080 |
Why?
|
Isoflavones | 1 | 2010 | 136 | 0.080 |
Why?
|
Aorta, Thoracic | 1 | 2016 | 1094 | 0.080 |
Why?
|
Protein Multimerization | 1 | 2014 | 979 | 0.080 |
Why?
|
Fatigue | 2 | 2018 | 1542 | 0.080 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2015 | 1240 | 0.080 |
Why?
|
Trinucleotide Repeats | 1 | 2010 | 257 | 0.080 |
Why?
|
Lung | 2 | 2018 | 9985 | 0.080 |
Why?
|
Mexico | 1 | 2011 | 758 | 0.080 |
Why?
|
Hypertension | 5 | 2023 | 8499 | 0.080 |
Why?
|
Outpatients | 1 | 2017 | 1591 | 0.080 |
Why?
|
Eyeglasses | 1 | 2010 | 137 | 0.080 |
Why?
|
Allied Health Personnel | 1 | 2010 | 155 | 0.080 |
Why?
|
Antipsychotic Agents | 1 | 2022 | 3060 | 0.080 |
Why?
|
Growth Hormone | 1 | 2010 | 568 | 0.080 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2015 | 1503 | 0.080 |
Why?
|
Family Health | 1 | 2013 | 1257 | 0.080 |
Why?
|
Heart Ventricles | 2 | 2010 | 3806 | 0.080 |
Why?
|
Disease Susceptibility | 1 | 2015 | 1788 | 0.080 |
Why?
|
Cluster Analysis | 4 | 2021 | 2697 | 0.080 |
Why?
|
Odds Ratio | 4 | 2017 | 9650 | 0.080 |
Why?
|
Iron | 2 | 2015 | 1786 | 0.080 |
Why?
|
Norwood Procedures | 1 | 2010 | 192 | 0.080 |
Why?
|
Peptide Fragments | 2 | 2017 | 5098 | 0.080 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2023 | 12075 | 0.070 |
Why?
|
Regression Analysis | 4 | 2013 | 6354 | 0.070 |
Why?
|
Linear Models | 5 | 2019 | 5862 | 0.070 |
Why?
|
Thinness | 1 | 2011 | 490 | 0.070 |
Why?
|
Cholecalciferol | 1 | 2013 | 549 | 0.070 |
Why?
|
Electroencephalography | 2 | 2022 | 6187 | 0.070 |
Why?
|
Phenotype | 2 | 2023 | 16534 | 0.070 |
Why?
|
C-Reactive Protein | 2 | 2017 | 3812 | 0.070 |
Why?
|
Coronary Vessels | 2 | 2016 | 3072 | 0.070 |
Why?
|
Bone Resorption | 1 | 2011 | 720 | 0.070 |
Why?
|
Hyperlipidemias | 2 | 2010 | 772 | 0.070 |
Why?
|
Sleep | 1 | 2023 | 4744 | 0.070 |
Why?
|
Reproduction | 1 | 2012 | 646 | 0.070 |
Why?
|
Compressive Strength | 1 | 2008 | 157 | 0.070 |
Why?
|
Hemoglobins | 3 | 2023 | 1519 | 0.070 |
Why?
|
Brazil | 1 | 2011 | 1217 | 0.070 |
Why?
|
Parkinson Disease | 1 | 2021 | 2862 | 0.070 |
Why?
|
Poverty | 1 | 2019 | 2692 | 0.070 |
Why?
|
Autoantibodies | 1 | 2016 | 2118 | 0.070 |
Why?
|
Population Groups | 1 | 2008 | 211 | 0.070 |
Why?
|
Diffusion Tensor Imaging | 1 | 2017 | 2386 | 0.070 |
Why?
|
Work Capacity Evaluation | 1 | 2006 | 45 | 0.070 |
Why?
|
Psychomotor Performance | 1 | 2015 | 1878 | 0.070 |
Why?
|
Hip | 1 | 2008 | 251 | 0.070 |
Why?
|
Medicare | 2 | 2022 | 6741 | 0.070 |
Why?
|
Feasibility Studies | 1 | 2017 | 5199 | 0.070 |
Why?
|
Physical Endurance | 1 | 2008 | 362 | 0.070 |
Why?
|
Endocrine System | 1 | 2006 | 112 | 0.070 |
Why?
|
Hepatocytes | 1 | 2013 | 1230 | 0.060 |
Why?
|
Epidemiologic Methods | 2 | 2009 | 1338 | 0.060 |
Why?
|
Urination Disorders | 1 | 2007 | 240 | 0.060 |
Why?
|
Heart | 1 | 2019 | 4382 | 0.060 |
Why?
|
Inflammation | 5 | 2023 | 10718 | 0.060 |
Why?
|
Chronic Disease | 2 | 2019 | 9267 | 0.060 |
Why?
|
Exercise Tolerance | 1 | 2010 | 830 | 0.060 |
Why?
|
Adolescent | 14 | 2023 | 87892 | 0.060 |
Why?
|
Down-Regulation | 2 | 2010 | 2904 | 0.060 |
Why?
|
Work | 1 | 2006 | 194 | 0.060 |
Why?
|
Sweden | 2 | 2018 | 1376 | 0.060 |
Why?
|
Cytosine | 1 | 2006 | 210 | 0.060 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14641 | 0.060 |
Why?
|
Guanine | 1 | 2006 | 278 | 0.060 |
Why?
|
Likelihood Functions | 1 | 2008 | 987 | 0.060 |
Why?
|
Energy Intake | 3 | 2017 | 2127 | 0.060 |
Why?
|
Injury Severity Score | 1 | 2008 | 1033 | 0.060 |
Why?
|
Blood Pressure | 2 | 2023 | 8451 | 0.060 |
Why?
|
Hypoplastic Left Heart Syndrome | 1 | 2010 | 594 | 0.060 |
Why?
|
Hip Joint | 1 | 2011 | 1006 | 0.060 |
Why?
|
Obesity | 5 | 2023 | 12870 | 0.060 |
Why?
|
Dehydroepiandrosterone | 1 | 2005 | 257 | 0.060 |
Why?
|
Myocardial Infarction | 2 | 2023 | 11424 | 0.060 |
Why?
|
Hypolipidemic Agents | 1 | 2009 | 609 | 0.060 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2006 | 783 | 0.060 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2717 | 0.060 |
Why?
|
Erythrocytes | 1 | 2013 | 2413 | 0.060 |
Why?
|
Transdermal Patch | 1 | 2023 | 51 | 0.050 |
Why?
|
Evidence-Based Medicine | 2 | 2020 | 3671 | 0.050 |
Why?
|
Prognosis | 3 | 2018 | 29557 | 0.050 |
Why?
|
Gene Frequency | 1 | 2010 | 3612 | 0.050 |
Why?
|
Enzyme Inhibitors | 1 | 2013 | 3709 | 0.050 |
Why?
|
Estrogen Replacement Therapy | 1 | 2009 | 1206 | 0.050 |
Why?
|
Prenatal Diagnosis | 1 | 2010 | 1264 | 0.050 |
Why?
|
Upper Extremity | 1 | 2008 | 661 | 0.050 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2010 | 1927 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3076 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3196 | 0.050 |
Why?
|
Safety | 1 | 2007 | 1147 | 0.050 |
Why?
|
Attitude to Health | 1 | 2011 | 2026 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2016 | 4048 | 0.050 |
Why?
|
Osteocalcin | 2 | 2017 | 274 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5331 | 0.050 |
Why?
|
Single-Blind Method | 2 | 2017 | 1570 | 0.050 |
Why?
|
Metabolism | 2 | 2016 | 193 | 0.050 |
Why?
|
Ovariectomy | 2 | 2014 | 610 | 0.050 |
Why?
|
Breast Neoplasms | 1 | 2009 | 21017 | 0.050 |
Why?
|
Atrial Fibrillation | 1 | 2020 | 5103 | 0.050 |
Why?
|
Quality Improvement | 1 | 2017 | 3806 | 0.050 |
Why?
|
Extremities | 2 | 2017 | 865 | 0.050 |
Why?
|
Kidney | 1 | 2017 | 7016 | 0.050 |
Why?
|
Acceleration | 1 | 2022 | 189 | 0.050 |
Why?
|
National Institute on Aging (U.S.) | 1 | 2021 | 39 | 0.050 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2012 | 2115 | 0.050 |
Why?
|
Data Interpretation, Statistical | 2 | 2008 | 2690 | 0.050 |
Why?
|
Hepatitis C | 1 | 2011 | 1579 | 0.050 |
Why?
|
Heart Function Tests | 2 | 2012 | 318 | 0.050 |
Why?
|
Age Distribution | 3 | 2016 | 2882 | 0.050 |
Why?
|
Multilevel Analysis | 1 | 2021 | 150 | 0.050 |
Why?
|
Statistics as Topic | 2 | 2017 | 2359 | 0.050 |
Why?
|
Hemodynamics | 1 | 2011 | 4159 | 0.050 |
Why?
|
Organ Size | 2 | 2017 | 2252 | 0.040 |
Why?
|
Adenine | 1 | 2006 | 975 | 0.040 |
Why?
|
Stroke Volume | 2 | 2012 | 5460 | 0.040 |
Why?
|
Visual Acuity | 1 | 2010 | 2642 | 0.040 |
Why?
|
Adult Children | 1 | 2020 | 103 | 0.040 |
Why?
|
Gene Expression Regulation | 3 | 2018 | 11892 | 0.040 |
Why?
|
Peripheral Arterial Disease | 1 | 2011 | 1246 | 0.040 |
Why?
|
Selection Bias | 1 | 2022 | 357 | 0.040 |
Why?
|
Anticholesteremic Agents | 1 | 2007 | 963 | 0.040 |
Why?
|
Rehabilitation | 1 | 2021 | 129 | 0.040 |
Why?
|
Sex Factors | 3 | 2020 | 10504 | 0.040 |
Why?
|
Herpes Zoster | 1 | 2002 | 251 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 3 | 2019 | 20500 | 0.040 |
Why?
|
Employment | 1 | 2006 | 1112 | 0.040 |
Why?
|
HIV Infections | 2 | 2020 | 17275 | 0.040 |
Why?
|
Men's Health | 1 | 2020 | 73 | 0.040 |
Why?
|
Sexual Behavior | 2 | 2024 | 2158 | 0.040 |
Why?
|
Purines | 2 | 2013 | 605 | 0.040 |
Why?
|
Blood Pressure Determination | 1 | 2023 | 634 | 0.040 |
Why?
|
Housing for the Elderly | 1 | 2019 | 16 | 0.040 |
Why?
|
Australia | 2 | 2015 | 1276 | 0.040 |
Why?
|
Personality Inventory | 1 | 2002 | 1018 | 0.040 |
Why?
|
Educational Status | 1 | 2007 | 2513 | 0.040 |
Why?
|
Collagen Type I | 2 | 2017 | 616 | 0.040 |
Why?
|
Brain | 2 | 2017 | 26947 | 0.040 |
Why?
|
Medical Errors | 1 | 2007 | 1255 | 0.040 |
Why?
|
Insulin | 3 | 2018 | 6578 | 0.040 |
Why?
|
Cross-Over Studies | 3 | 2014 | 2048 | 0.040 |
Why?
|
Depressive Disorder, Major | 1 | 2016 | 4745 | 0.040 |
Why?
|
Remote Sensing Technology | 1 | 2019 | 92 | 0.040 |
Why?
|
Pelvic Floor | 1 | 2019 | 138 | 0.040 |
Why?
|
Menopause, Premature | 1 | 2019 | 124 | 0.040 |
Why?
|
Erythrocyte Count | 1 | 2018 | 157 | 0.040 |
Why?
|
Program Evaluation | 1 | 2007 | 2492 | 0.040 |
Why?
|
Pandemics | 3 | 2023 | 8611 | 0.040 |
Why?
|
Retirement | 1 | 2019 | 197 | 0.040 |
Why?
|
Heart Failure | 1 | 2022 | 11593 | 0.040 |
Why?
|
Ventricular Function, Left | 1 | 2010 | 3858 | 0.040 |
Why?
|
Interleukin-1beta | 1 | 2023 | 996 | 0.040 |
Why?
|
Education, Medical, Undergraduate | 1 | 2007 | 1066 | 0.040 |
Why?
|
Lung Volume Measurements | 1 | 2018 | 375 | 0.040 |
Why?
|
Patient Acceptance of Health Care | 1 | 2011 | 3175 | 0.040 |
Why?
|
Vitamins | 2 | 2018 | 1632 | 0.040 |
Why?
|
Students, Medical | 2 | 2007 | 1927 | 0.040 |
Why?
|
Supine Position | 1 | 2017 | 205 | 0.030 |
Why?
|
Internship and Residency | 2 | 2007 | 5865 | 0.030 |
Why?
|
Temperature | 1 | 2023 | 2219 | 0.030 |
Why?
|
Teriparatide | 1 | 2018 | 227 | 0.030 |
Why?
|
Procollagen | 1 | 2017 | 187 | 0.030 |
Why?
|
Intelligence Tests | 1 | 2017 | 500 | 0.030 |
Why?
|
Solubility | 1 | 2018 | 1088 | 0.030 |
Why?
|
Neuralgia | 1 | 2002 | 600 | 0.030 |
Why?
|
Chromosomes, Human, X | 1 | 2018 | 321 | 0.030 |
Why?
|
Benzodiazepines | 1 | 2022 | 1130 | 0.030 |
Why?
|
Hyperalgesia | 1 | 2000 | 530 | 0.030 |
Why?
|
Dehydroepiandrosterone Sulfate | 2 | 2007 | 240 | 0.030 |
Why?
|
Ferritins | 1 | 2018 | 597 | 0.030 |
Why?
|
New South Wales | 1 | 2015 | 70 | 0.030 |
Why?
|
Financing, Government | 1 | 2019 | 472 | 0.030 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2016 | 6013 | 0.030 |
Why?
|
Self-Assessment | 1 | 2017 | 393 | 0.030 |
Why?
|
Meta-Analysis as Topic | 1 | 2020 | 1373 | 0.030 |
Why?
|
Infection Control | 1 | 2022 | 982 | 0.030 |
Why?
|
Ankle Joint | 1 | 2019 | 435 | 0.030 |
Why?
|
Internet | 1 | 2007 | 3082 | 0.030 |
Why?
|
Feedback, Sensory | 1 | 2014 | 56 | 0.030 |
Why?
|
Lipids | 2 | 2018 | 3326 | 0.030 |
Why?
|
Pilot Projects | 2 | 2022 | 8553 | 0.030 |
Why?
|
Pain Measurement | 3 | 2017 | 3527 | 0.030 |
Why?
|
Eflornithine | 1 | 2013 | 31 | 0.030 |
Why?
|
Thiamine | 1 | 2015 | 160 | 0.030 |
Why?
|
Phosphorus | 1 | 2015 | 335 | 0.030 |
Why?
|
Ornithine Decarboxylase | 1 | 2013 | 64 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2023 | 1793 | 0.030 |
Why?
|
Primary Health Care | 2 | 2020 | 4652 | 0.030 |
Why?
|
RNA, Viral | 1 | 2022 | 2836 | 0.030 |
Why?
|
Middle Cerebral Artery | 1 | 2015 | 275 | 0.030 |
Why?
|
Prostate-Specific Antigen | 1 | 2023 | 2528 | 0.030 |
Why?
|
Anthropometry | 1 | 2018 | 1347 | 0.030 |
Why?
|
Diphosphonates | 1 | 2018 | 636 | 0.030 |
Why?
|
beta Carotene | 1 | 2015 | 523 | 0.030 |
Why?
|
Alkaline Phosphatase | 1 | 2017 | 865 | 0.030 |
Why?
|
Androstenedione | 1 | 2013 | 131 | 0.030 |
Why?
|
Lipoproteins | 1 | 2018 | 881 | 0.030 |
Why?
|
Pain Threshold | 1 | 2017 | 603 | 0.030 |
Why?
|
Diabetes Complications | 2 | 2012 | 1317 | 0.030 |
Why?
|
Sensory Thresholds | 1 | 2014 | 377 | 0.030 |
Why?
|
Pelvis | 1 | 2018 | 743 | 0.030 |
Why?
|
Blood Flow Velocity | 1 | 2017 | 1370 | 0.030 |
Why?
|
Movement | 1 | 2020 | 1474 | 0.030 |
Why?
|
Allosteric Regulation | 1 | 2014 | 426 | 0.030 |
Why?
|
Self Efficacy | 1 | 2017 | 632 | 0.030 |
Why?
|
Radioimmunoassay | 1 | 2013 | 866 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2017 | 22029 | 0.030 |
Why?
|
Orgasm | 1 | 2012 | 61 | 0.030 |
Why?
|
Follistatin | 1 | 2013 | 137 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2020 | 2676 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2020 | 2189 | 0.030 |
Why?
|
Skilled Nursing Facilities | 1 | 2017 | 394 | 0.030 |
Why?
|
Neoplasms | 2 | 2020 | 22032 | 0.030 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2022 | 1469 | 0.030 |
Why?
|
Penile Erection | 1 | 2012 | 100 | 0.030 |
Why?
|
Premenopause | 1 | 2017 | 1038 | 0.030 |
Why?
|
Smad Proteins | 1 | 2013 | 156 | 0.030 |
Why?
|
Preventive Health Services | 1 | 2017 | 570 | 0.030 |
Why?
|
Chi-Square Distribution | 2 | 2010 | 3425 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2007 | 3227 | 0.030 |
Why?
|
Sebum | 1 | 2012 | 17 | 0.030 |
Why?
|
Mendelian Randomization Analysis | 1 | 2018 | 993 | 0.030 |
Why?
|
Range of Motion, Articular | 1 | 2019 | 1583 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2017 | 1680 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2008 | 7985 | 0.030 |
Why?
|
Health Services | 1 | 2017 | 752 | 0.020 |
Why?
|
Coitus | 1 | 2012 | 132 | 0.020 |
Why?
|
Vitamin A | 1 | 2015 | 613 | 0.020 |
Why?
|
Transferrin | 1 | 2013 | 284 | 0.020 |
Why?
|
Trauma Centers | 2 | 2008 | 933 | 0.020 |
Why?
|
Retrospective Studies | 5 | 2022 | 80168 | 0.020 |
Why?
|
Magnesium | 1 | 2015 | 809 | 0.020 |
Why?
|
Analysis of Variance | 2 | 2010 | 6234 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2017 | 931 | 0.020 |
Why?
|
Depressive Disorder | 1 | 2024 | 3727 | 0.020 |
Why?
|
Risk | 2 | 2017 | 9599 | 0.020 |
Why?
|
K562 Cells | 1 | 2013 | 639 | 0.020 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2012 | 278 | 0.020 |
Why?
|
Survival Analysis | 2 | 2018 | 10112 | 0.020 |
Why?
|
Zinc | 1 | 2015 | 687 | 0.020 |
Why?
|
Hypophysectomy | 1 | 2010 | 114 | 0.020 |
Why?
|
Prefrontal Cortex | 1 | 2021 | 2209 | 0.020 |
Why?
|
Mice, Transgenic | 2 | 2013 | 9518 | 0.020 |
Why?
|
Peptides | 2 | 2017 | 4341 | 0.020 |
Why?
|
Soybean Proteins | 1 | 2010 | 55 | 0.020 |
Why?
|
Hematocrit | 1 | 2012 | 627 | 0.020 |
Why?
|
Knee Joint | 1 | 2019 | 1663 | 0.020 |
Why?
|
Antidepressive Agents | 1 | 2002 | 2889 | 0.020 |
Why?
|
Smoking | 2 | 2020 | 9051 | 0.020 |
Why?
|
Parathyroid Hormone | 1 | 2017 | 1797 | 0.020 |
Why?
|
Interpersonal Relations | 1 | 2017 | 1433 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2018 | 1878 | 0.020 |
Why?
|
Urban Health | 1 | 2012 | 533 | 0.020 |
Why?
|
Nutritional Status | 1 | 2018 | 1607 | 0.020 |
Why?
|
Urban Population | 1 | 2017 | 2025 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2022 | 3754 | 0.020 |
Why?
|
Ethanol | 1 | 2015 | 1323 | 0.020 |
Why?
|
Observer Variation | 1 | 2015 | 2600 | 0.020 |
Why?
|
Fibrinogen | 1 | 2012 | 883 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 2 | 2010 | 6493 | 0.020 |
Why?
|
Parents | 1 | 2022 | 3548 | 0.020 |
Why?
|
Orchiectomy | 1 | 2010 | 470 | 0.020 |
Why?
|
Arousal | 1 | 2014 | 1157 | 0.020 |
Why?
|
Hospitals | 1 | 2022 | 3887 | 0.020 |
Why?
|
Brain Concussion | 1 | 2019 | 1397 | 0.020 |
Why?
|
Receptor, IGF Type 1 | 1 | 2010 | 380 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2018 | 15773 | 0.020 |
Why?
|
DNA Methylation | 1 | 2022 | 4373 | 0.020 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2013 | 841 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 2011 | 983 | 0.020 |
Why?
|
Intraoperative Care | 1 | 2011 | 766 | 0.020 |
Why?
|
Patient Compliance | 1 | 2017 | 2685 | 0.020 |
Why?
|
Injections | 1 | 2010 | 830 | 0.020 |
Why?
|
Waist-Hip Ratio | 1 | 2008 | 516 | 0.020 |
Why?
|
Cholesterol | 1 | 2016 | 2902 | 0.020 |
Why?
|
Sampling Studies | 1 | 2008 | 614 | 0.020 |
Why?
|
Fatty Liver | 1 | 2013 | 777 | 0.020 |
Why?
|
Child | 5 | 2012 | 79818 | 0.020 |
Why?
|
Algorithms | 2 | 2016 | 13961 | 0.020 |
Why?
|
Postoperative Period | 1 | 2010 | 1812 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2012 | 1474 | 0.020 |
Why?
|
Anxiety | 1 | 2020 | 4539 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2017 | 1831 | 0.020 |
Why?
|
Pulmonary Veins | 1 | 2011 | 745 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3774 | 0.020 |
Why?
|
California | 1 | 2009 | 1419 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2010 | 1705 | 0.020 |
Why?
|
Postmenopause | 1 | 2014 | 2509 | 0.020 |
Why?
|
Heart Atria | 1 | 2011 | 1344 | 0.020 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2018 | 3339 | 0.020 |
Why?
|
Polypharmacy | 1 | 2007 | 305 | 0.010 |
Why?
|
Kinetics | 1 | 2012 | 6371 | 0.010 |
Why?
|
Patient Discharge | 1 | 2017 | 3433 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2013 | 6520 | 0.010 |
Why?
|
Epidemiologic Studies | 1 | 2007 | 670 | 0.010 |
Why?
|
Electrocardiography | 1 | 2017 | 6363 | 0.010 |
Why?
|
Gene Expression | 1 | 2016 | 7583 | 0.010 |
Why?
|
Risk Management | 1 | 2007 | 557 | 0.010 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2012 | 1704 | 0.010 |
Why?
|
Demography | 1 | 2008 | 1651 | 0.010 |
Why?
|
Genotype | 1 | 2018 | 12945 | 0.010 |
Why?
|
Proportional Hazards Models | 2 | 2009 | 12440 | 0.010 |
Why?
|
Sex Distribution | 1 | 2008 | 2284 | 0.010 |
Why?
|
Knee | 1 | 2004 | 276 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 6293 | 0.010 |
Why?
|
Heart Rate | 1 | 2014 | 4166 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 4839 | 0.010 |
Why?
|
Calcium | 1 | 2015 | 5721 | 0.010 |
Why?
|
Sickness Impact Profile | 1 | 2002 | 298 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2010 | 3432 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2011 | 2058 | 0.010 |
Why?
|
Mice | 3 | 2013 | 81101 | 0.010 |
Why?
|
Stroke | 1 | 2023 | 9694 | 0.010 |
Why?
|
Mass Screening | 1 | 2016 | 5427 | 0.010 |
Why?
|
Radiography | 1 | 2011 | 6954 | 0.010 |
Why?
|
Schools, Medical | 1 | 2007 | 877 | 0.010 |
Why?
|
Signal Transduction | 2 | 2013 | 23342 | 0.010 |
Why?
|
Educational Measurement | 1 | 2007 | 1248 | 0.010 |
Why?
|
Social Class | 1 | 2009 | 1999 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2005 | 2850 | 0.010 |
Why?
|
Factor Analysis, Statistical | 1 | 2002 | 999 | 0.010 |
Why?
|
Pain | 1 | 2015 | 5065 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 2012 | 4018 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2010 | 8143 | 0.010 |
Why?
|
Capsaicin | 1 | 2000 | 231 | 0.010 |
Why?
|
Ultrasonography | 1 | 2012 | 5952 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2013 | 7590 | 0.010 |
Why?
|
Forecasting | 1 | 2008 | 2923 | 0.010 |
Why?
|
Injections, Subcutaneous | 1 | 2000 | 677 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2018 | 12604 | 0.010 |
Why?
|
Physical Stimulation | 1 | 2000 | 518 | 0.010 |
Why?
|
Patient Selection | 1 | 2010 | 4244 | 0.010 |
Why?
|
Learning | 1 | 2007 | 1739 | 0.010 |
Why?
|
Medically Uninsured | 1 | 2002 | 836 | 0.010 |
Why?
|
Diet | 1 | 2015 | 8005 | 0.010 |
Why?
|
Population Surveillance | 1 | 2007 | 2606 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2008 | 3561 | 0.010 |
Why?
|
Animals | 3 | 2013 | 167768 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2013 | 22003 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2010 | 18940 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2012 | 4761 | 0.010 |
Why?
|
Decision Making | 1 | 2008 | 3915 | 0.010 |
Why?
|
Rats | 1 | 2010 | 23679 | 0.010 |
Why?
|
Heart Diseases | 1 | 2006 | 2782 | 0.010 |
Why?
|
Social Support | 1 | 2002 | 2155 | 0.010 |
Why?
|
Health Behavior | 1 | 2002 | 2617 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2010 | 26183 | 0.010 |
Why?
|
Child, Preschool | 1 | 2012 | 42062 | 0.010 |
Why?
|
Pregnancy | 1 | 2010 | 29742 | 0.000 |
Why?
|